Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal N Padte

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Immunology (Orlando, Fla.)|December 28, 2010
Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvantNeal N Padte, Xiangming Li, Moriya Tsuji, et al.
Current Biology : CB|December 5, 2006
The cell-end factor pom1p inhibits mid1p in specification of the cell division plane in fission yeastNeal N Padte, Sophie G Martin, Martin Howard, et al.
Retrovirology|August 31, 2018
Engineering multi-specific antibodies against HIV-1Neal N Padte, Jian Yu, Yaoxing Huang, et al.
Journal of Cell Science|July 3, 2009
Nuclear shape, growth and integrity in the closed mitosis of fission yeast depend on the Ran-GTPase system, the spindle pole body and the endoplasmic reticulumYanira Gonzalez, Kristen Meerbrey, Jennifer Chong, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 24, 2014
Rational design and characterization of the novel, broad and potent bispecific HIV-1 neutralizing antibody iMabm36Ming Sun, Craig S Pace, Xin Yao, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 30, 2016
Distinct HIV-1 Neutralization Potency Profiles of Ibalizumab-Based Bispecific AntibodiesRuijiang Song, Craig Pace, Michael S Seaman, et al.
Scientific Reports|September 2, 2020
The influence of proline isomerization on potency and stability of anti-HIV antibody 10E8Miklos Guttman, Neal N Padte, Yaoxing Huang, et al.
Molecular Therapy. Methods & Clinical Development|October 17, 2017
In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola InfectionsChasity D Andrews, Yang Luo, Ming Sun, et al.
Cell|June 18, 2016
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing ActivityYaoxing Huang, Jian Yu, Anastasia Lanzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2020
Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivoPengfei Wang, Mili R Gajjar, Jian Yu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Immunology (Orlando, Fla.)|December 28, 2010
Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvantNeal N Padte, Xiangming Li, Moriya Tsuji, et al.
Current Biology : CB|December 5, 2006
The cell-end factor pom1p inhibits mid1p in specification of the cell division plane in fission yeastNeal N Padte, Sophie G Martin, Martin Howard, et al.
Retrovirology|August 31, 2018
Engineering multi-specific antibodies against HIV-1Neal N Padte, Jian Yu, Yaoxing Huang, et al.
Journal of Cell Science|July 3, 2009
Nuclear shape, growth and integrity in the closed mitosis of fission yeast depend on the Ran-GTPase system, the spindle pole body and the endoplasmic reticulumYanira Gonzalez, Kristen Meerbrey, Jennifer Chong, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 24, 2014
Rational design and characterization of the novel, broad and potent bispecific HIV-1 neutralizing antibody iMabm36Ming Sun, Craig S Pace, Xin Yao, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 30, 2016
Distinct HIV-1 Neutralization Potency Profiles of Ibalizumab-Based Bispecific AntibodiesRuijiang Song, Craig Pace, Michael S Seaman, et al.
Scientific Reports|September 2, 2020
The influence of proline isomerization on potency and stability of anti-HIV antibody 10E8Miklos Guttman, Neal N Padte, Yaoxing Huang, et al.
Molecular Therapy. Methods & Clinical Development|October 17, 2017
In Vivo Production of Monoclonal Antibodies by Gene Transfer via Electroporation Protects against Lethal Influenza and Ebola InfectionsChasity D Andrews, Yang Luo, Ming Sun, et al.
Cell|June 18, 2016
Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing ActivityYaoxing Huang, Jian Yu, Anastasia Lanzi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2020
Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti-HIV-1 IgG1 antibodies in vivoPengfei Wang, Mili R Gajjar, Jian Yu, et al.
Pageof 2